pedijatrija izbori asistenata · h [ j z a z p - 1 m g b < ? j a b l ? l m ; : 5 h 3 e m p b n : d...

50
Ɉɛɪɚɡɚɰ - 1 ɍɇɂȼȿɊɁɂɌȿɌ ɍ ȻȺȵɈȳ Ʌɍɐɂ ɎȺɄɍɅɌȿɌ: Ɇɟɞɢɧɫɤɢ ɮɚɤɭɥɬɟɬ ɂɁȼȳȿɒɌȺȳ ɄɈɆɂɋɂȳȿ ɨ ɩɪɢʁɚɜʂɟɧɢɦ ɤɚɧɞɢɞɚɬɢɦɚ ɡɚ ɢɡɛɨɪ ɧɚɫɬɚɜɧɢɤɚ ɢ ɫɚɪɚɞɧɢɤɚ ɭ ɡɜɚʃɟ I. ɉɈȾȺɐɂ Ɉ ɄɈɇɄɍɊɋɍ Ɉɞɥɭɤɚ ɨ ɪɚɫɩɢɫɢɜɚʃɭ ɤɨɧɤɭɪɫɚ, ɨɪɝɚɧ ɢ ɞɚɬɭɦ ɞɨɧɨɲɟʃɚ ɨɞɥɭɤɟ: Ɉɞɥɭɤɚ ɋɟɧɚɬɚ ɍɧɢɜɟɪɡɢɬɟɬɚ ɭ ɛɚɧʁɚɥɭɰɢ, ɛɪɨʁ ɨ ɢɡɛɢɪɭ ɫɚɪɚɞɧɢɤɚ ɡɚ ɭɠɭ ɧɚɭɱɧɭ ɨɛɥɚɫɬ ɉȿȾɂȳȺɌɊɂȳȺ, 8 ɢɡɜɪɲɢɥɚɰɚ ɍɠɚ ɧɚɭɱɧɚ/ɭɦʁɟɬɧɢɱɤɚ ɨɛɥɚɫɬ: ɉȿȾɂȳȺɌɊɂȳȺ ɇɚɡɢɜ ɮɚɤɭɥɬɟɬɚ: Ɇɟɞɢɰɢɧɫɤɢ ɮɚɤɭɥɬɟɬ Ȼɪɨʁ ɤɚɧɞɢɞɚɬɚ ɤɨʁɢ ɫɟ ɛɢɪɚʁɭ ɨɫɚɦ (8) Ȼɪɨʁ ɩɪɢʁɚɜʂɟɧɢɯ ɤɚɧɞɢɞɚɬɚ ɫɟɞɚɦ (7) Ⱦɚɬɭɦ ɢ ɦʁɟɫɬɨ ɨɛʁɚɜʂɢɜɚʃɚ ɤɨɧɤɭɪɫɚ: ϮϲϴϮϬϭϱ. ɞɧɟɜɧɢ ɥɢɫɬ "Ƚɥɚɫ ɋɪɩɫɤɟ" Ȼɚʃɚɥɭɤɚ ɋɚɫɬɚɜ ɤɨɦɢɫɢʁɟ: ɚ) ɞɪ ȳɟɥɢɰɚ ɉɪɟɞɨʁɟɜɢʄ ɋɚɦɚɪʇɢʄ, ɪɟɞɨɜɚɧ ɩɪɨɮɟɫɨɪ, ɭɠɚ ɧɚɭɱɧɚ ɨɛɥɚɫɬ ɉɟɞɢʁɚɬɪɢʁɚ, Ɇɟɞɢɰɢɧɫɤɢ ɮɚɤɭɥɬɟɬ ɍɧɢɜɟɪɡɢɬɟɬɚ ɭ Ȼɚʃɨʁ Ʌɭɰɢ, ɩɪɟɞɫʁɟɞɧɢɤ ɛ) ɞɪ ɋɧɟɠɚɧɚ ɉɟɬɪɨɜɢʄ-Ɍɟɩɢʄ, ɞɨɰɟɧɬ, ɭɠɚ ɧɚɭɱɧɚ ɨɛɥɚɫɬ ɉɟɞɢʁɚɬɪɢʁɚ,

Upload: others

Post on 19-Oct-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

  • - 1

    :

    I.

    , : ,

    , 8

    / :

    :

    (8)

    (7)

    : . " "

    :

    ) , , , ,

    ) - , , ,

  • , ) , , ,

    ,

    : 1. 2. 3. 4. 5. 6. 7.

    II.

    ) : ( ) : ( )

    : 08.08.1970.

    : - , (1996-2005.)

    - ( 2005.

    ) : - –

    ,

    , (1996-2000.) -

    (2000-2004.)

    - (2004-2013.)

    - , (

    2013. )

    :

    -

    - -

    ) :

  • : ,

    : : , 1995.

    : 9,10 :

    : : : : / (

    ):

    : / :

    : , , .

    :

    -

    : "

    – – LLIC

    BFM 2002 LLIC BFM 2009" / (

    ): ,

    ( , , )

    ) /

    / ( 19. 20.)

    1. ,

    1.1. Konjevi S, uki D, Stanimirovi B, Blagojevi A, Bobi V, Banjac B.

    Peripherally inserted central catheter complications – our experiences. Signa Vitae. 2015;10 (suppl 1):16-19.

    ( ) ,

  • . 30 (VLBW, ELBW) 2012.

    2015. . , : 1- 1000 – 1500

    (VLBW) 2 – 1000 ( LBW). , , ,

    ( , ). 30 .

    ( ), ( =0.241).

    ( =0.598).

    WLBW LBW, .

    0,3 x 4=1,2 1.2. Stanimirovi B, Konjevi S, ur evi -Banjac B, uki D, Peji D, Mr a

    J. Macrophage activation syndrome in child with systemic onset of juvenile idiopathic arthritis. Signa Vitae 2015;10 (suppl 1):55-57.

    ( )

    , ( , )

    . : , , ,

    , , .

    . , ,

    . .

    0,3 x 4 =1,2

    1.3. Vranješ D, Spremo S, Travar D, Aleksi A, ur evi -Banjac B. Acute

    otitis media in children: correlation with palatine tonsil size, adenoidectomy and adenotonsillectomy. Paediatr Today 2014;10 (1):1-7.

    ,

    . 12 , 160 , 6 7 .

    ( 1 2). ,

  • . .

    ( =0.213). 26.8% , 55.4% ,

    17.9% . ( =0.019).

    .

    .

    0,5 x 4 = 2,0

    2. Nau ni rad na skupu me unarodnog zna aja, štampan u zborniku

    izvoda radova

    2.1. ur evi -Banjac B, Krstovski N, Jani D, Predojevi -Samardži J, Dokmanovi L, Mal i D, Lazi J, Rodi P. Predictors of acute chemotherapy – associated toxicity in children with ALL. SIOP abstracts, , 46th Congres of the international society of paediatric oncology (SIOP) 2014, Toronto, Canada. Pediatr Blood Cancer; 2014: 152 - 153.

    123 1 18 ( 7.11 , 5.5 ),

    , ALLIC BFM 2002 ( –

    – ), 2002. 2010. . ,

    . 98.35%

    . ( =0.973), ( =0.847), ( =0.994), ( =0.979), ( =894)

    (0.608) ( =929), ( =994) ( =908)

    .

    ( =0.056, =0.181). ( =0.047),

    (

  • 0,3 x 3 = 0,9

    : 5,3 ) :

    / ( ( , )

    21.) : 0

    ) :

    / ( 22.) 2.

    2.1. - . , . : - , . . :

    Grafid; 2013. . 52-59. 0,5 x 3= 1,5

    1. :

    1.1. - , , , ,

    - , . . ,

    . , 2010: 54.

    ( ).

    2006. 2010. . , .

    . 71 , 81.3 .

    , 128 . (39.8%).

    96 (75%). ( , , , , )

    . (48.7%). 5

    (3%).

  • .

    .

    0,3 x 3=0,9

    1.2. - , - , - ,

    . 2003. 2011.

    . , 2. . , 2011:190.

    ( ) ( ), ,

    . 1.1.2003. 31.12.2012.

    , . ,

    . 78.2% .

    (52.17%), 12;21 / 1 (47.8%).

    , .

    0,75 x 3 = 2,25

    1.3. - , , , - , - .

    . , . , 2010:51.

    ( ).

    . ,

    . , .

    156 , 52 18 26 .

    4 .

    0,5 x 3=1,5 boda

    1.4. - , , , -

  • , . Joint health and funcional ability in children with hemophilia in Bosnia and Herzegovina. Book of abstracts, 13th International Musculosceletal Congres. Chicago, 2013:48.

    ,

    , ( , ).

    .

    – joint HSPH (Harvard School of Public Health) (Pedatric Hemophilia Activity List) .

    0,5 x 3 = 1.5 boda

    1.5. , , - , - ,

    . . , 3

    . , 2006: 189.

    -

    . 27.12.2002 . 3540 . 9/10.

    , . ,

    , .

    – 1.25 . ,

    , . –

    . 0,5 x 3= 1,5

    1.6. - , , - , , , .

    . , 3. . ,

    2006: 189. ( )

  • . .

    17 ( ),

    .

    . ,

    ,

    . . - ,

    .

    .

    0,3 x 3 = 0,9

    2. : 2.1. - , , M , ,

    . . u , , .

    Scr Med 2007; 1(1 ): 119.

    ,

    ,

    , .

    . .

    0,5 x 2 = 1,0 2.2. - , , , ,

    , , . . u . ,

    . Scr Med. 2007; 1 (1 ): 119.

  • .

    . ,

    0,3 x 2 = 0,6

    11,65

    : 16,95

    ) :

    ( ) : ( ) —

    : 28.11.1974. , : 1. ,

    ( 2000 - 2002)

    2. ,

    ( 2002 - : 1. ,

    ( 2000 - 2002) 2. ,

    :

    – - ( 2002- 2003)

    – ( 2003-

    2008) – ( 2008 - )

    :

    - ,

    - Ko ,

    -

  • .

    ) :

    : ,

    : : , 2000.

    : 9,29 :

    : ,

    : - : - : ''

    ''

    ( 27.9.2013. ) / (

    ):

    : 10,00 / :

    :

    :

    : / (

    ):

    ( , , )

    ) /

    / ( 19. 20.)

    , :

    1. Davidovi B, Predojevi – Samardži J, Uletilovi S, Mal i D, Sani anin Ž.

    Activities of proximal tubules enzymes in urine of patients treated with gentamicin. B 2007; 26:46-50.

    , ( ), ( )

    - - - - ( ). 12-

  • 30 , - , . 10 .

    30 . .

    , / ,

    ( < 0,01). .

    .

    0,5x10=5

    2. Davidovi – Plavši B, Vuji T, Uletilovi S, Predojevi – Samardži J, Mal i D, Sani anin Ž. Urinary activities of proximal tubule enzymes in neonates treated with gentamicin. JMB 2010; 29 ( 1 ):44-47.

    : ( ), ( ) -

    - - - ( ). 30 .

    , ( <

    0,01). - - - - .

    .

    0,3x10=3

    :

    1. , - , , , .

    . 2007; 46:1-3.

    ,

    , 10 ,

    . 30 3 10

    .

  • 30 . 10 .

    (p < 0,05). .

    0,5x6=3

    2. , , - , – , , .

    . 2009; 2:175-79.

    12-

    , , , - - - - , , 30 . . 30

    . . 10 .

    , / , (p < 0,05).

    , ,

    . 0,3x6=1,8

    12,8 :

    / ( ( , )

    21.)

    0

    ) : /

    ( 22.)

    :

    1. , , , . . Scr med

    2009; 40 (1):37-40.

    , .

  • , , .

    . ,

    . ,

    .

    0,75x2 = 1,5

    :

    1. . - , , - , . Clear cell

    . 14. , , 2003.

    ''clear cell'' . ,

    .

    , .

    ''clear cell'' . .

    .

    0,75x3=2,25

    2. , - , , , . . XV

    , 2006.

    - ( ), , . .

    10 . 60 , ,

    3 10 . 10 . j ( < 0,01), 3

    10 , .

    .

    0,5x3= 1,5

  • 3. - , , - , , , .

    . radova 3. k . 2-5 2006.

    17 ,

    2002 .

    . ,

    . - ,

    . :

    .

    .

    .

    0,3x3= 0,9

    4. , , . e .

    , 2007.

    21 ( ) 1999. 2007. .

    Y 95, 2002. , 17 . 219 ,

    29.68% , 32.87% . , 69.4% , 16.4% , 7.76% 6.39%

    , 14.61% . : .

    .

    .

    3

    5. Predojevi -Samardži , Djurdjevic-Banjac B, Mal i -Zani D. Some characteristics of patients with haemophillia in Republic of Srpska – Bosnia and Herezegovina. In Proceedings of the 15th Danubian League Meeting against Thrombosis and Haemorrhagic Disorders, Belgarde, May 14-16, 2009: 58.

  • , , , , .

    ,

    .

    . .

    .

    .

    .

    3

    6. - , , , , . .

    , 2010.

    ( ).

    . ,

    . , .

    156 , 52 18 26 . 4

    .

    0,5×3 = 1,5

    7. , , - , .

    2003. 2011 . , , 2011.

    a ( ), , .

    1.1.2003. 31.12.2011. , .

    , . 78.2% .

    (52.17%), 12;21 / 1

    (47.8%). ,

  • .

    0,75×3= 2,25

    8. Djurdjevi -Banjac B, Krstovski N, Jani D, Predojevic-Samardzic J, Dokmanovi L, Mal i -Zani D, Lazi J, Rodi P. Predictors of acute chemotherapy associated toxicity in children with ALL. Proceedings of the 46. Congress of the international society paediatric oncology ( SIOP) Toronto, 2014.

    123 1 18 ( 7.11 , 5.5 ),

    , 2002 ( – – ),

    2002. 2010. . ,

    . 98.35% . ( =0.973), ( =0.847), ( =0.994),

    ( =0.979), ( =894) (0.608) ( =929), ( =994) ( =908)

    .

    ( =0.056, =0.181). ( =0.047),

    (

  • 0,5×2=1

    2. , , , , , ,

    . . , , 2007. 2007; 1

    (1):119.

    . .

    , .

    0,3×2=0,6

    :

    1. .

    19/06-020/961-84/11 30.12.2011. . . 1

    19,40 : 32,20

    ) : ( ) : ( )

    : 17.03.1977. :

    ( 10.05.2004. )

    : ,

    - (2004-2005.), -

    (2005-2009.), - (2009-

    2012.), -

  • ( 2012. )

    :

    - ,

    - Ko ,

    - .

    ) :

    : ,

    : : , 2003.

    : 9,14 :

    : ,

    : - : - : "

    "

    ( 28.01.2014.) / (

    ):

    : 9,90 / :

    :

    :

    : / (

    ):

    ( , , )

    ) /

    / ( 19. 20.)

    1. ,

    :

  • 1.1. Mari J., ulum J., Kordi O., Simatovi M., Krivoku a B., Despot B.,

    Staki I., Kecman G., Gajanin R., ur evi - Mari N. Observation of planned and registered neuroendocrine tumors (NETS) in the Banja Luka region. BH Surgery. 2011;1:39 – 44.

    , , ,

    .

    .

    . ( 2006. 2010.)

    . , 10 (71,4%), , , ,

    ( ). 5 (35.7%), - 1 2 6 (42,8%)

    ( 3) 8 (57,2%). 9 (64,3%) . , PFS (progression-free

    survival).

    ,

    . .

    .

    0,3 x 10 = 3 3

    ) :

    / ( ( , )

    21.) 0

    ) :

    / ( 22.)

  • 2. 2.1. - . . .

    , 2013. . - : , . 28-29, , . 30-32, , . 60-61 , 62-63.

    0,5 x 3 = 1,5

    3. :

    3.1. Mari N., Serdar B., Simi E., Stanimirovi B. Duchennne muscular dystrophy and neurofibromatosis type I coexisting in the same patient – case report. Folia Medica Facultatis Medicinae Universitatis Saraeviensis. 2014 (suppl 1): 49.

    . Jedna

    , X- ,

    5 100000 . 1, - , ,

    , 23 100000 . . .

    , multiplex PCR. 1 ,

    . , ,

    1. .

    , . ,

    , .

    0,75 x 2 = 1,5 4. :

    4.1. Mari N. Rare diseases detected in genetic counseling in Republic of Srpska. Book of abstracts, Symposium Genomics of Rare Diseases. Beograd. 2014: 60.

    .

    , ,

  • 90 . 80% ,

    . 2009. 7,8 .

    .

    110 48 . , .

    , .

    3

    4.2. Maleševi R., Ivankovi B., Bukara Radujkovi G., Stomornjak-Vukadin M., Mari N., Kurtovi -Baši I., Haveri A. A case of a girl with pseudodicentric chromosome X. Book of abstracts, V Congress of Serbian Genetic Society. Belgrade. 2014.

    o FISH .

    . X X 95% ,

    5% X. FISH 3 X 96% :

    X. 4% X

    X. FISH .

    0,3 x 3 = 0,9

    4.3. ., ., - ., ., . - . , 43.

    . . 2011: 187-88.

    , , , .

    , .

    1 , .

    8 .

    1

  • . , - , ,

    . ,

    . ,

    .

    . , ,

    .

    0,5 x 3 = 1,5

    4.4. ., ., - ., ., ., . - .

    , . . 2010.

    . .

    ( ) ( ) . .

    24. , .

    . , , . , Staphyloccus aureusa.

    . .

    . , ,

    . ,

    , . : ,

    , , , . ,

    , .

    0,5 x 3 = 1,5 4.5. ., ., - ., .,

    ., . .

  • , . . 2010.

    .

    .

    , .

    . ,

    . .

    .

    0,3 x 3 = 0,9 4.1. ., ., - ., ., .

    . Book of abstracts, South East European Congress in Perinatal Medicine. . 2009.

    . , :

    ( ), ( ), ( ) ( ). 150

    3. 5. . : ( ), ( ),

    ( ), - ( ),

    ( ), ( ), ( ), ( ), ( ), ( ),

    ( ) ( / ). ( ): 1,50;

    1,73, 1,79; 23,8; 3,56; 1,88; 2,05, 2,11; 2,38, 2,36; 7,72, 7,77; 28,02,

    27,98; ( ) 7,14; 5,0; 11,37; 39,79; / 0,29; 6,05, 5,96.

    . . , , , / .

    , . :

    , ,

    , , .

  • 0,5 x 3 = 1,5 4.2. ., - ., ., ., .

    . , 6. . . . 2007.

    9 30% . ,

    .

    2005. ,

    , . 272 . 145 (53,3%),

    127 (46,7%). 17 (6,25%) , 13 , 7

    1,500 . , , , .

    , .

    0,5 x 3 = 1,5 4.3. ., ., , .

    . 50. - . . 2006: 331 – 34.

    .

    - .

    .

    .

    . 28. . ,

    , 32 , .

    0,75 x 3 = 2,25 4.4. ., - ., ., .

    . , . . . 2006.

    0,1 0,4% , 2 4%.

    . , .

  • -

    1.4.2004. 1.3.2005. . ,

    . 2008 (72,2%) 1877 .

    77, 54, .

    194 (9,6%). ( )

    ( ) 81 (41%) 12 (13%). , , 8 (66%), 2,

    0,9 . .

    .

    , - , , , , ,

    , . 0,75 x 3 = 2,25

    5. :

    5.1. ., - ., ., ., .,

    ., ., ., .

    2002. 2006. , – . Scripta Medica. 2007. 1 (1 suppl): 2 – 3.

    1 600 .

    . .

    .

    01. 2002. 31. 2006. . 15 , .

    1 950 . 8, 7 .

    6 . .

    , .

  • 0,3 x 2 = 0,6 5.2. ., ., ., - ., -

    ., . Fallot,

    . , – . Scripta Medica. 2007. 1 (1 suppl): 3.

    Fallot, ,

    .

    , , .

    . ,

    , .

    01. 2002. 31. 2006.

    . 218 , Fallot

    20 (9,17%) , 9 (4,13%)

    5 (2,3%) . :

    .

    . .

    , .

    0,3 x 2 = 0,6

    19,5

    : 22,5

    ) : ( ) : ( )

    : 09.06.1973. : ( 05.02.2001.

    31.12.2001. )

  • ( 01.01.2002. )

    : - ( 2001-2002.),

    ,

    - (2002-2004.), -

    (2004-2008.), - (2008-

    2015.), -

    ( 17.06. 2015.).

    :

    - ,

    - Ko ,

    - -

    ( European Cystic Fibrosis Society)

    ) :

    : ,

    : : , 2000.

    : 8,00 :

    : ,

    : - : - : " -

    "

  • ( 10.03.2011.) / (

    ):

    : 9,93 / :

    :

    :

    : / (

    ):

    ( , , )

    ) /

    / ( 19. 20.)

    0 ) :

    / ( ( , )

    21.) 0

    ) : /

    ( 22.) 1.

    1.1 , , , - , .

    . Curr Top Neurol Psychiatr Relat Discip 2010; XVIII (2): 46-49.

    je .

    : , . , ,

    , , , - . , , .

  • , , .

    ,

    , .

    .

    , .

    0,5x 4 = 2

    2.

    2.1 , , , . . Scr Med 2009;

    40 (1):37-40.

    ,

    . , , .

    . ,

    . , .

    0,75x2 = 1,5 2.2 , , , - , , , . : . Scr Med 2010; 41(1):199-203.

    12- , 2010. ,

    .

    . , ,

    , - , chinococcus granulosus, ,

    . .

  • 0,3x2 = 0,6

    2.3 , , , , . . Respiratio 2014; (1-2):321-324.

    -

    . - 28- .

    ( 1480 , 8/9, 30 ). ,

    , .

    ( ) ,

    , .

    .

    0,5x2 = 1

    3. :

    3.1 - , , , , , , . Our experiences in the application of combined amoxicillin and clavulonic acid in the initial treatment of neonatal meningitis and sepsis. Abstract book, 13th Annual Congress of the European Society of Paediatric and Neonatal Intensive Care (ESPNIC), Ljubljana,Slovenija, 2002.

    3.

    . 747 2000. 48 .

    . . ,

    , .

    , .

    ,

  • . .

    . 58,1%

    ,

    12,9%.

    .

    .

    .

    0,3x3 = 0,9

    3.2 , , - , - , . .

    ra 3. k , , , 2006.

    , . 0.7/1000 .

    , .

    .

    , .

    - . ,

    . - ,

    . 27.12.2002. . 3540 , 9/10, 41.

    , .

  • , ,

    . - . ,

    , .

    .

    0,5x3=1,5

    3.3 , , . . , 45. , , 2013.

    . ,

    . 1-3 , .

    , . 50% .

    , , .

    , . . 6 3 ,

    .

    . , ,

    , .

    , , .

    . , .

    3

    3.4 . , , . - . , , , 2014.

    ( ) ycobacterium tuberculosis. .

    16.5 , 3,5 ,

  • . . : , , .

    , . : .

    . . , 16,5 ,

    . : , , . . 80, 64 / . :

    - . , . ,, ,,

    , . ,

    , .

    , .

    3

    4. :

    4.1 - , - , - , - , , . 2003. 2013. . , 3. , , , , 2013.

    ( ) .

    , . 3

    : , . .

    ( ) , .

    1.12.2003 . 31.12.2013 . ( ,

    ) .

    .

  • 0,3x2= 0,6

    4.2 , , , - , , - , . . , , , , 2007.

    ( )

    1979. .

    . 2002. 2006.

    .

    1498 16% . (59,7%), (56,85%) 63,1%.

    5,5 , 69,3% .

    , , .

    0,3x2= 0,6

    4.3 - , , - , , - , , , , . . , , , , 2007.

    , (1:

    10000 ). . .

    19. (19q) 1, . , . -

  • - , . : ,

    , , , , .

    . , 35 , 2600 ,

    ,

    , .

    0,3x2= 0,6

    4.4 , , , , , - , , , . . , , , , 2007.

    10 15% . ( ), 5%

    . , ,

    . ( ) 48 .

    ,

    . 2002. 2006. .

    2,5% 16,2% , .

    , 2.500 , 38 . 4,8. 8 39 ,

    . , .

    .

    0,3x2= 0,6

  • 4.5 , , , , , . . , , , , 2007.

    . . , ,

    . ( , ).

    , . ,

    2001. 2006. . 7 (3 4 ), 3

    ( , ).

    , . (43%)

    .

    0,3x2= 0,6 : 16,5

    ) :

    ( ) : ( ) : 15.11.1976. ,

    : - , (2001-2002. )

    - ( 1.2.2002. )

    : - , ,

    ( 2001. 2002. ) -

    , • (2002-

    2004. ) •

  • (2004-2008. )

    • (2008-2012. )

    • ( 2012. )

    :

    • PRINTO (Pediatric Rheumatology International Trials)

    • ULARA (The European league against rheumati m)

    ) :

    : ,

    : : , 2001.

    : 8,56 :

    : : : : / (

    ):

    : / :

    : , ,

    :

    3.

    : / (

  • ):

    ( , , )

    , ,

    (2001-2002. )

    ) /

    / ( 19. 20.)

    0 ) :

    /

    ( ( , ) 21.)

    0 ) :

    / ( 22.) 1. :

    1.1. Stanimirovi B, Konjevi S, Banjac ur evi B, uki D, Peji D, Mr a J. Macrophag activation syndrome in a child with systemic onset of juvenile idiopathic artritis.Signa Vitae 2015;10(1):55-57.

    ( )

    , , . -

    , , , , , .

    , , .

    .

    , , .

    .

    0,3 x 4=1,2

  • 1.2.Konjevi S, uki D, Stanimirovi B, Blagojevi A, Bobi V, Banjac

    ur evi B. Peripherally inserted central catheter complications in neonates-our experiences, Signa Vitae 2015;10 (1):16-19.

    .

    30

    2012. 2015. . , , , , ,

    , . : 1. (

    1000 1500 2. ( 1000 ). 40

    , 30 (75%). 13 1 11 2.

    (p=0,598).

    ,

    , .

    0,3 x 4=1,2 1.3.Peji D, Savi S, Popovi M, Ceri Bani evi A, Stanimirovi B, Mr a J. Gestational trophoblastic disease with multisistemic complications.Signa Vitae 2015; 10 ( 1):79-80.

    ( ) , , ,

    . 16.

    . .

    1 082 900 mIU/ml.

    . 16 341 mIU/ml,

    2 . 0,3 x 4=1,2 a

    1.4. uki D, Baji S, Parezanovi V, Konjevi S, Stanimirovi B, Bobi V.Rare congenital coronary anomaly-unroofed coronary sinus, Signa Vitae 2015;10 (

  • 1):58-60.

    . ,

    .

    . . .

    .

    , .

    .

    0,3 x4=1,2 2. :

    2.1. Mari N, Serdar B, Simi E, Stanimirovi B. Duchennne muscular dystrophy and neurofibromatosis type I coexisting in the same patient – case report. Folia Medica 2014; (1): 49

    . X-

    , 5 100000 . 1, - , ,

    , 23 100000 .

    . ,

    multiplex PCR. 1 , - .

    , ,

    1. .

    ,

  • . 0,75 x 2 = 1,5

    3. :

    3. 1.Stanimirovic B, Susic G, Novakovic D, Stojanovic R. Systemic lupus erythematosus (SLE) in children and adolescents in Pediatric unite, Institute of rheumatology Belgrade, Serbia. Abstract book, 20th Pediatric Rheumatology European Society (PReS) Congress, Ljubljana, Slovenia, 2013.

    .

    , , . 10

    ( 2001. 2011. ) .37 (36 , 1 ) .

    15 (7-19). ( 84,8% , 69,7%), ( 87,9%)

    ( 75,8%, 69,7%, 18,9%). 45,5% .

    51,2% . 97,3%, 81,1% . 100% , 97,3%,

    48,6%, 21,6% . , .

    ,2 ( ).

    0,75x3=2,25

    3.2. Predojevi - Samardži J, Novakovi V, Solomon Lj, Kovacevic T, Mirošljevi V, Ljuboja O, Maksimovi B. Our experiences in the application of combined amoxicillin and clavulonic acid in the initial treatment of neonatal meningitis and sepsis. Abstract book, 13th Annual Congress of the European Society of Paediatric and Neonatal Intensive Care (ESPNIC), Ljubljana, Slovenia, 2002.

    3.

    . 747 2000. 48 .

    . . ,

    , .

  • , .

    , .

    .

    . 58,1%

    ,

    12,9%.

    .

    .

    .

    0,3x3=0,9 4. :

    4.1. Stanimirov B, Peji D, Mr a J. Dual energy-X-ray absorbtiometry in children with chronic rheumatic diseases. Zbornik sažetaka radova, 8.Me unarodni nau ni skup Savremeni materijali, Banja Luka, Bosna i Hercegovina, 2015.

    . (DXA)

    (BMD) . . ,

    .

    . ,

    , , , , .

  • 0,75x2=1,5

    4.2. Mr a J, Peji D, Stanimirovi B, Mr a V. Tocilizumab as biologic therapy in adults with rheumatoid arthritis. Zbornik sažetaka radova, 8.Me unarodni nau ni skup Savremeni materijali, Banja Luka, Bosna i Hercegovina, 2015.

    , , .

    .

    -6 .

    . , ,

    .

    .

    0,75x2=1,5 4.3. Peji D, Stanimirovi B, Mr a J, Peji -Gali B, Selective fetoscopic laser photocoagulation therapy for twin –twin transfusion syndrome.Zbornika sažetaka radova, 8.Me unarodni nau ni skup Savremeni materijali, Banja Luka, Bosna i Hercegovina, 2015.

    ( ) 10 15 % o .

    ,

    . , , ,

    , j , , . .

    . ,

    .

    ( ) .

    . .

  • 0,75x2=1,5

    : 13,95

    ) : ( ) : ( , )

    : 23.04.1974., : -

    – ( - 1993)

    - – ( - 1995)

    - Berlin-Chemie – (2003-2004)

    - ( 2004-) : 1.

    - 2. –

    -

    3. Berlin-Chemie –

    - 4.

    - /

    :

    -

    -

    -

    -

    ) :

    : : : 2003. ,

    : 8,25 :

  • : : : - : „

    “ / (

    ):

    : / :

    :

    :

    : / (

    ):

    ( , , )

    ) /

    / ( 19. 20.)

    0

    ) :

    / ( ( , )

    21.)

    0

    ) : /

    ( 22.)

    : 0

    ) : ( ) : ( , )

    : 31.01.1972.

  • : , ,

    : , . . , ,

    :

    ,

    ) :

    : : : ,1997

    : 8,63 :

    : : : : / (

    ):

    : / :

    :

    :

    : / (

    ):

    ( , , )

    ) /

    / ( 19. 20.)

  • , -

    .

    0.5 3 = 1.5

    1,5

    ) :

    / ( ( , )

    21.) 0

    ) : /

    2009. 2013.

    : 1,5

  • ,

    10

    92,9

    12,8

    0

    19,40

    125,10

    91,4

    3

    0 19,50 113,90

    91

    5,3

    0

    11,65

    107,95

    85,6 0 0 13,95 99,55

    80 0 0 16,50 96,50

    86,3 1,5 0 0 87,80

    82,5 0 0 0 82,50

  • III.

    77., 78., 79., 80. („ “, 110/73, 104/11, 84/12

    108/13) 18-36. .

    ,

    77. ( 8 ( ) .

    26. ,

    : 1. 125,10 2. 113,90 3. 107,95 4. 99,55 5. 96,50 6. 87,80 7. 82,50

    -

    .

    , 05.02.2016.

    :

    1. , ,

    , ,

    _________________________________

    2. - , , ,

    , _________________________________

    3. , , , , __________________________________